News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TG Therapeutics, Inc. (MHA) To Present At The 32nd Annual J.P. Morgan Healthcare Conference


1/14/2014 9:25:26 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, Jan. 13, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced that Michael Weiss, the Company's Interim Chief Executive Officer, will be presenting at the 32nd Annual J.P. Morgan Healthcare Conference, being held at the Westin St. Francis Hotel in San Francisco. Mr. Weiss will discuss updates on the Company's two lead compounds for hematologic malignancies; TG-1101 (ublituximab) and TGR-1202. The presentation is scheduled to take place on Thursday, January 16, 2014 at 1:00 PM PST. A live webcast of this presentation will be available on the Events page of the Company's website at www.tgtherapeutics.com.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES